Product Information
SEVELAMER CARBONATE 800 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.2140 per EA under NDC 76282040727. Its NADAC has been published 332 times since May 27, 2020.
FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282040727
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SEVELAMER CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA203860FDA Approved
10/26/2017
TE Code
AB
On Market Since
11/8/2017
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER CARBONATE 800 MG TAB has been published 332 times since May 27, 2020, and over the history we have for it it has declined 43.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2140 per EA |
|---|---|
| All-time high | $0.3830 (Jul 15, 2020) |
| All-time low | $0.1833 (Nov 20, 2024) |
| 52-week high | $0.2285 |
| 52-week low | $0.2074 |
| Median price | $0.2379 |
| Average price | $0.2547 |
| Largest weekly change | -26.6% (Jan 20, 2021) |
| Weeks tracked | 332 |
| Tracking since | May 27, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SEVELAMER CARBONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER CARBONATE 800 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER CARBONATE 800 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.2140 per EA (NDC 76282040727), effective Sep 30, 2026.
How has the price of SEVELAMER CARBONATE 800 MG TAB changed over time?
Over the history we have for it, the NADAC for SEVELAMER CARBONATE 800 MG TAB has declined 43.4%. It has been tracked across 332 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for SEVELAMER CARBONATE 800 MG TAB?
Since May 27, 2020, the NADAC for SEVELAMER CARBONATE 800 MG TAB has ranged from a low of $0.1833 (Nov 20, 2024) to a high of $0.3830 (Jul 15, 2020), with a median of $0.2379 per EA.
Are there cheaper alternatives to SEVELAMER CARBONATE 800 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SEVELAMER CARBONATE 800 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures SEVELAMER CARBONATE 800 MG TAB?
SEVELAMER CARBONATE 800 MG TAB (NDC 76282040727) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.